# One Pass Tirofiban In Management of Ischemic Stroke Thrombectomy In China

Study · id `cardio:ct-nct04851457` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04851457](<https://clinicaltrials.gov/study/NCT04851457>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04851457

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

## Technical summary

Registry record NCT04851457. Randomized; single masking; primary purpose treatment. Start 2021-04-06 (actual); primary completion 2023-07-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 200 participants (enrolled count; ClinicalTrials.gov record NCT04851457, source copy `cardio:ctgov-nct04851457-2024-01-09`, retrieved 2026-10-26)
- Started: 2021-04-06 (actual) (ClinicalTrials.gov record NCT04851457, source copy `cardio:ctgov-nct04851457-2024-01-09`, retrieved 2026-10-26)
- Primary completion: 2023-07-08 (actual) (ClinicalTrials.gov record NCT04851457, source copy `cardio:ctgov-nct04851457-2024-01-09`, retrieved 2026-10-26)
- Completion: 2023-10-15 (actual) (ClinicalTrials.gov record NCT04851457, source copy `cardio:ctgov-nct04851457-2024-01-09`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04851457, source copy `cardio:ctgov-nct04851457-2024-01-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04851457-2024-01-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: One Pass Tirofiban In Management of Ischemic Stroke Thrombectomy In China
- Acronym: OPTIMISTIC
- Condition: Ischemic Stroke
- Intervention (Drug): Intravenous tirofiban combination therapy
- Lead sponsor: Shanghai East Hospital
- Lead sponsor class: OTHER
- Collaborator: Shanghai 6th People's Hospital
- Collaborator class: OTHER
- Collaborator: Ningbo No. 1 Hospital
- Collaborator class: OTHER
- Collaborator: Zhangzhou Municipal Hospital of Fujian Province
- Collaborator class: OTHER
- Collaborator: Shanghai 7th People's Hospital
- Collaborator class: OTHER
- Collaborator: Jinan Central Hospital
- Collaborator class: OTHER
- Collaborator: Xuchang Central Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Shanghai East Hospital (`cardio:org-shanghai-east-hospital`)
- Registry lists this organization as a collaborator: Shanghai 6th People's Hospital (`cardio:org-shanghai-6th-people-s-hospital`)
- Registry lists this organization as a collaborator: Ningbo No. 1 Hospital (`cardio:org-ningbo-no-1-hospital`)
- Registry lists this organization as a collaborator: Shanghai 7th People's Hospital (`cardio:org-shanghai-7th-people-s-hospital`)
- Registry lists this organization as a collaborator: Jinan Central Hospital (`cardio:org-jinan-central-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Tirofiban on First-Pass Recanalization in Acute Stroke Endovascular Thrombectomy: The OPTIMISTIC Randomized Clinical Trial (`cardio:pubmed-40244586`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 3180d46ca63706c194c45e5bf1a846a204931e6a7b78cd7874b71cfbd048ec34
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
